28 related articles for article (PubMed ID: 38479574)
1. Inflammation and Myocardial Blood Flow in Cardiac Sarcoidosis.
Parihar AS; Valenta I; Mikhail S; Imperiale A; Schindler TH
Curr Cardiol Rep; 2024 May; ():. PubMed ID: 38775909
[TBL] [Abstract][Full Text] [Related]
2. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
3. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
4. Pre-Treatment Myocardial
Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
6. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
Lee PI; Cheng G; Alavi A
J Nucl Cardiol; 2017 Feb; 24(1):19-28. PubMed ID: 27813028
[TBL] [Abstract][Full Text] [Related]
7. Role of serial
Okafor J; Khattar R; Kouranos V; Ohri S; Diana D; Ebeke E; Azzu A; Ahmed R; Wells A; Baksi AJ; Sharma R; Wechalekar K
J Nucl Cardiol; 2024 May; 35():101842. PubMed ID: 38479574
[TBL] [Abstract][Full Text] [Related]
8. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Campisi R; Merani MF; Rodríguez MI
Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
[TBL] [Abstract][Full Text] [Related]
10. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
Ohira H; Tsujino I; Yoshinaga K
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
